Ross Jeffrey S, Symmans W Fraser, Pusztai Lajos, Hortobagyi Gabriel N
Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York 12208, USA.
Adv Clin Chem. 2005;40:99-125. doi: 10.1016/s0065-2423(05)40003-7.
Substantial progress has been made over the past three decades in our understanding of the epidemiology, clinical course and basic biology of breast cancer. This chapter considers the existing ancillary tests and emerging molecular markers in breast cancer prognosis assessment and the prediction of response of breast cancer to treatment of the disease.
在过去三十年里,我们对乳腺癌的流行病学、临床病程和基础生物学的认识取得了重大进展。本章探讨了乳腺癌预后评估中现有的辅助检测方法和新兴分子标志物,以及乳腺癌对疾病治疗反应的预测。